Home>Topics>Stocks>Myriad Genetics

Myriad Genetics MYGN

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. Cramer's Mad Money - The World Is Slowing, And Slowing Fast (9/16/14)

      Headlines

      Wed, 17 Sep 2014

      By SA Editor Miriam Metzinger : Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday September 16. Note to Fed: The World Is Slowing, And Slowing Fast The world is slowing, and slowing fast. China has now become a huge negative, Alibaba aside. The iPhone in China

    2. Update: Myriad Genetics' Patents Are Facing Trouble Again

      Headlines

      Mon, 25 Aug 2014

      By Andy Batts : Genetic diagnostics lab GeneDx filed eleven petitions to invalidate patent claims held by Myriad Genetics (NASDAQ: MYGN ), according to a recent report . This is the first move against Myriad's patents to take advantage of

    3. New Morningstar Analyst Report for Myriad Genetics Inc

      Stock Reports

      Thu, 21 Aug 2014

      Strong cash flow generation has enabled the firm to begin to return cash to shareholders in the form of share repurchases. Myriad Genetics develops genetic diagnostic products, and is best known for its BRACAnalysis test, which assesses a woman’s risk of

    4. Midday Gainers / Losers

      Headlines

      Wed, 13 Aug 2014

      REED +13% . EVK +13% . OTCQB:AMTX +12% . ASPN +12% . Top 10 Losers: SEAS -32% . KING -23% . NLST -15% . INPH -14% . RIGL -12% . KWK -12% . SIGA -11% . EVRY -12% . MYGN -10% . FATE -10% . Post your comment!

    5. Initial Uptake of Myriad's MyRisk Panel Test Remains Encouraging

      Commentary

      Wed, 13 Aug 2014

      Myriad Genetics reported fourth-quarter earnings Tuesday that were largely in line with our expectations as growth saw headwinds from revised

    6. Myriad provides 2015 guidance after fiscal Q4 results

      Headlines

      Tue, 12 Aug 2014

      Myriad Genetics ( MYGN -3.3% ) fiscal Q4 and full year results : Fiscal Q4 Revenues: $188.8M (+8.4%); Operating Income: $53.3M

    7. Myriad Genetics profit forecast misses estimates

      Headlines

      Tue, 12 Aug 2014

      Aug 12 (Reuters) - Molecular diagnostics company Myriad Genetics Inc forecast a lower-than-expected full-year adjusted profit, hurt partly by the termination of its contract with affordable health insurance provider Horizon Blue Cross in May.

    8. After Hour Gainers / Losers

      Headlines

      Tue, 12 Aug 2014

      Top gainers, as of 5:15 p.m.: SRPT +5.9% . REXX +5.1% . PE +4.6% . MHR +4.3% . NPSP +4.3% . Top losers, as of 5:15 p.m.: KING -21.1% . ARWR -11.9% . QNST -9.8% . CREE -6.3% . MYGN -5.1% . Post your comment!

    9. Notable earnings after Tuesday's close

      Headlines

      Mon, 11 Aug 2014

      CHMI , CREE , EPAY , FMI , FOSL , FTD , HMIN , JDSU , JKHY , KING , MYGN , OTC:OPWR , PE , PRSS , SYNC , TCX , URS , VSAT Post your comment!

    10. Stock Picking Matters in the Current Market Climate

      Headlines

      Thu, 26 Jun 2014

      confident about right now? I discussed Myriad Genetics in January, and I still really like the ..... portfolios for more than a decade. Like Myriad Genetics , its share price has been somewhat volatile in 2014, but ..... 0.00 0.00 0.00 1.32 0.00 Myriad Genetics 3.18 1.90 3.56 4.02 0.00

    « Prev12345Next »
    Content Partners